Comparative study of neutralising antibody titres against the three different interferon-beta preparations using a unique and validated assay

被引：0
|
作者：
Deisenhammer, F [1 ]
Gneiss, C [1 ]
Reichartseder, F [1 ]
Reindl, M [1 ]
Berger, T [1 ]
机构：
[1] Innsbruck Med Univ, Innsbruck, Austria
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 15 条
  • [1] Comparative study of neutralizing antibody titres against the three different interferon-beta preparations using a unique and validated assay
    Deisenhammer, F
    Gneiss, C
    Reichartseder, F
    Reindl, M
    Berger, T
    NEUROLOGY, 2005, 64 (06) : A326 - A326
  • [2] Antibody binding properties of different interferon beta preparations: a comparative study of antibody titres and binding affinity
    Dujmovic, I.
    Walchshofer, R.
    Hoelzl, M.
    Hegen, H.
    Paz, P.
    Croze, E.
    Deisenhammer, F.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S424 - S424
  • [3] Influence of interferon beta switching on neutralising antibody titres: The Austrian Switch Study (ASS)
    Gneiss, C.
    Millonig, A.
    Reindl, M.
    Berget, T.
    Deisenhammer, F.
    MULTIPLE SCLEROSIS, 2007, 13 : S32 - S32
  • [4] Three ranges of titres of neutralising antibodies present different risk of loss of interferon-beta biological activity in vivo in multiple sclerosis patients
    Sala, A.
    Capobianco, M.
    Malucchi, S.
    di Sapio, A.
    Caldano, M.
    Marnetto, F.
    Valentino, P.
    Gilli, F.
    Bertolotto, A.
    MULTIPLE SCLEROSIS, 2006, 12 : S206 - S207
  • [5] Comparative study of four different assays for the detection of binding antibodies against interferon-beta
    Gneiss, C
    Brugger, M
    Reindl, M
    Berger, T
    Ehling, R
    Lutterotti, A
    Khalil, M
    Künz, B
    Mayringer, I
    Deisenhammer, F
    MULTIPLE SCLEROSIS, 2005, 11 : S159 - S160
  • [6] Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study
    Gneiss, Claudia
    Koudouovoh-Tripp, Pia-Maria
    Ropele, Stefan
    Gotwald, Thaddaeus
    Ehling, Rainer
    Lutterotti, Andreas
    Aichner, Franz
    Ladurner, Gunther
    Eggers, Christian
    Schautzer, Franz
    Kuenz, Bettina
    Millonig, Alban
    Aspeck, Engelbert
    Reindl, Markus
    Berger, Thomas
    Fazekas, Franz
    Deisenhammer, Florian
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (12) : 1481 - 1488
  • [7] A comparative study of the relative bioavailability of different interferon beta preparations
    Deisenhammer, F
    Mayringer, I
    Harvey, J
    Dilitz, E
    Gasse, T
    Stadlbauer, D
    Reindl, M
    Berger, T
    NEUROLOGY, 2000, 54 (11) : 2055 - 2060
  • [8] Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study)
    Magyari, Melinda
    Sondergaard, Helle Bach
    Sellebjerg, Finn
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (02) : 141 - 146
  • [9] Variability of the assessment of anti-interferon β neutralising antibody using the same assay in three Italian centres
    Antonelli, G
    Bellomi, F
    Russo, P
    Baranello, C
    Sessa, E
    Bramanti, P
    La Volpe, V
    Trojano, M
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S254 - S255
  • [10] HLA-DRB1*15 and HLA-A*02 are associated with higher risk of developing neutralising antibodies and clinically relevant titres against interferon-beta in multiple sclerosis
    Link, J.
    Lundkvist, M.
    Fink, K.
    Hermanrud, C.
    Brynedal, B.
    Fogdell-Hahn, A.
    Kockum, I.
    Hillert, J.
    JOURNAL OF NEUROLOGY, 2012, 259 : S149 - S149
12